HIGHLIGHTS
- who: Huaying Xie and colleagues from the University Mu00fcnster, Germany have published the article: GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC, in the Journal: (JOURNAL)
- what: The authors examined the regulatory roles and clinicopathologic significance of GLDC in TNBC and determined the underlying mechanism. The kit for DualLuciferase Reporter Assay System was obtained from Promega Corporation and the experiment was performed as the protocol provided by the supplier. In the present study, the results showed that GLDC, which was significantly up-regulated in cancer tissues, facilitated cell proliferation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.